The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Credit Facility to TP Group

16 Dec 2021 10:30

RNS Number : 9018V
Science Group PLC
16 December 2021
 

 

 

 

16 December 2021

 

Science Group plc ("Science Group")

 

Credit Facility to TP Group

 

 

 

 

Following the appointment of the two Science Group nominees to the TP Group plc ("TP Group") Board, Science Group supports the new strategy set out by TP Group on 1 November 2021 which is consistent with the model outlined in the Science Group strategic investment.

 

From the outset, Science Group consistently highlighted to TP Group both the benefits of a potential partnership and the potential challenges as an independent entity. In particular, over the summer, Science Group noted the going concern commentary in the TP Group 2020 Annual Report. To mitigate certain risks and provide a more robust financial platform, Science Group recently offered, and the independent directors of TP Group have accepted, a standby revolving credit facility (the "Facility"). It is not certain that the Facility will be required but it provides additional headroom to allow the TP Group Board to execute its new strategy.

 

The Facility is for up to £5 million for the period from the date of signing until 30 September 2023. The Facility, which is unsecured, includes an arrangement fee of 3%, interest rate on drawn amounts of 1% per month and a rate of 0.4% per month of any undrawn amount, both subject to Sterling Overnight Index Average (SONIA) remaining below 1%. The Facility can be cancelled or refinanced by TP Group with a third party at any time and without penalty or early termination charges but while in place the terms of the agreement protect Science Group from material shareholder or board dilution. As a result of the Science Group facility being provided, TP Group's bank has amended and eased covenants and extended the existing bank loan to 30 September 2023.

 

As directors of both companies, Martyn Ratcliffe and Peter Bertram have not participated in any decisions of the Boards of either TP Group nor Science Group in relation to the Facility.

 

 

End

 

Science Group plc

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

Nick Adams, Alex Price

Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Joint Broker)

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFIFALRLIL
Date   Source Headline
21st Nov 20228:51 amRNSForm 8.5 (EPT/NON-RI)
21st Nov 20227:00 amRNSPublication of Scheme Document
17th Nov 20229:16 amRNSForm 8.5 (EPT/NON-RI)
16th Nov 20229:03 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
16th Nov 20228:33 amRNSForm 8.3 - TP Group PLC
14th Nov 20228:55 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20228:32 amRNSForm 8.3 - TP Group PLC
11th Nov 20228:18 amRNSForm 8.3 - TP Group PLC
10th Nov 20227:00 amRNSForm 8 (OPD) (TP Group plc)
7th Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
4th Nov 202211:31 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
4th Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
3rd Nov 202210:23 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
3rd Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
2nd Nov 202211:00 amRNSForm 8.5 (EPT/NON-RI)
2nd Nov 202210:44 amRNSForm 8 (DD) - TP Group plc
2nd Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
1st Nov 20224:38 pmRNSForm 8.3 - TP Group Plc
1st Nov 202210:33 amRNSRule 2.10 - M&G Letter of Intent
1st Nov 20229:25 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
31st Oct 20225:22 pmRNSForm 8 (OPD) - TP Group plc
31st Oct 20227:00 amRNSRecommended Cash Aquisition of TP Group plc
31st Oct 20227:00 amRNSBusiness Update
26th Oct 20227:00 amRNSResignation of Auditor
27th Sep 20229:23 amRNSResult of General Meeting
21st Sep 20227:00 amRNSHalf-year Report
2nd Sep 20227:00 amRNSPublication of Accounts
15th Aug 20227:00 amRNSAudited results for year ended 31 December 2021
12th Jul 20223:43 pmRNSCompletion of Disposal
28th Jun 20221:07 pmRNS2021 Financial Update
28th Jun 202210:43 amRNSResult of Annual General Meeting
21st Jun 202211:05 amRNSSecond Price Monitoring Extn
21st Jun 202211:00 amRNSPrice Monitoring Extension
20th Jun 20222:48 pmRNSExtension to Publication of Results
1st Jun 20221:27 pmRNSNotice of AGM and Accounts Update
26th May 20224:50 pmRNSSale of Sapienza Consulting Ltd.
1st Apr 20227:00 amRNSDisposal
31st Mar 20227:00 amRNSDirectorate Change
11th Feb 20227:00 amRNSBusiness Update
16th Dec 202110:30 amRNSCredit Facility to TP Group
16th Dec 202110:26 amRNSBusiness Update
1st Nov 20217:00 amRNSBusiness and Board Update
29th Oct 20215:00 pmRNSWithdrawal of GM Requisition - Replacement
29th Oct 20211:20 pmRNSWithdrawal of GM Requisition
29th Oct 202111:21 amRNSDirectorate Change
26th Oct 20211:15 pmRNSResponse re. Science Group Announcement
26th Oct 20217:00 amRNSRequisition of General Meeting of TP Group plc
14th Oct 20217:00 amRNSDirectorate Changes
11th Oct 20217:00 amRNSTrading and Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.